NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/21/2023
Back to search
Official data from USPTO
MEDIX INFUSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDIX INFUSION
ST13
US500000090639535Class
42, 44
Filing
90639535
Registration
7007186
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/21/2023
Trademark type
Word
Nice classes
42, 44
Filing date
04/12/2021
Registration date
03/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
03/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/29/2022
First use in commerce
12/29/2022
Drawing code
4
Owner type
03
Owner location
Addison, TX
Examiner
BATT, JAIME
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MEDIX INFUSION, INC.
Representatives
Ann K. Ford DLA PIPER LLP (US)
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting clinical trials for othersmonitoringreview and analysis of patient pharmaceutical compliance
Class 44
Healthcare servicesInfusion therapy services; healthcare servicesinfusion of pharmaceuticals in the home and in office infusion suites and centers for the treatment of chronic illnesses; leasing of medical equipmentproviding instruments and apparatus for administering prescription medication
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/16/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/15/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/11/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/11/2023
IUAF
USE AMENDMENT FILED
01/13/2023
EISU
TEAS STATEMENT OF USE RECEIVED
01/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/18/2022
EX1G
SOU EXTENSION 1 GRANTED
03/16/2022
EXT1
SOU EXTENSION 1 FILED
03/16/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/16/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/18/2022
PUBO
PUBLISHED FOR OPPOSITION
01/18/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/29/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/08/2021
GNRT
NON-FINAL ACTION E-MAILED
12/08/2021
CNRT
NON-FINAL ACTION WRITTEN
12/08/2021
DOCK
ASSIGNED TO EXAMINER
12/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2021
NWAP
NEW APPLICATION ENTERED
04/15/2021
Continuous trademark protection
Get notified about every new filing that threatens MEDIX INFUSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.